Chad J. Wasserman - Feb 2, 2024 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role
SVP and CIO
Signature
/s/ Kevin A. Ball, Attorney-in-Fact
Stock symbol
HCA
Transactions as of
Feb 2, 2024
Transactions value $
-$215,208
Form type
4
Date filed
2/6/2024, 06:28 PM
Previous filing
Feb 6, 2024
Next filing
Feb 21, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCA Common Stock Sale -$203K -652 -69.19% $312.04 290 Feb 2, 2024 Direct F1, F2
transaction HCA Common Stock Options Exercise +127 +43.75% 417 Feb 3, 2024 Direct F2, F3
transaction HCA Common Stock Tax liability -$11.8K -38 -9.11% $309.42 379 Feb 3, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCA Restricted Stock Units Options Exercise $0 -127 -49.8% $0.00 128 Feb 3, 2024 Common Stock 127 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $312.0111 to $312.06, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 Includes 35.3102 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.
F3 Restricted stock units convert into common stock on a one-for-one basis.
F4 The restricted stock units vest in two equal annual installments beginning February 3, 2024.